Legato Capital Management LLC Acquires Shares of 8,110 HealthEquity, Inc. (NASDAQ:HQY)

Legato Capital Management LLC acquired a new stake in shares of HealthEquity, Inc. (NASDAQ:HQY) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund acquired 8,110 shares of the company’s stock, valued at approximately $778,000.

A number of other hedge funds have also added to or reduced their stakes in the stock. UMB Bank n.a. grew its position in shares of HealthEquity by 65.6% in the 4th quarter. UMB Bank n.a. now owns 414 shares of the company’s stock worth $40,000 after buying an additional 164 shares during the period. Quarry LP grew its position in shares of HealthEquity by 418.8% in the 3rd quarter. Quarry LP now owns 1,349 shares of the company’s stock worth $110,000 after buying an additional 1,089 shares during the period. 1620 Investment Advisors Inc. purchased a new stake in shares of HealthEquity in the 3rd quarter worth about $112,000. GAMMA Investing LLC grew its position in shares of HealthEquity by 32.9% in the 4th quarter. GAMMA Investing LLC now owns 1,248 shares of the company’s stock worth $120,000 after buying an additional 309 shares during the period. Finally, Covestor Ltd grew its position in shares of HealthEquity by 27.4% in the 3rd quarter. Covestor Ltd now owns 1,524 shares of the company’s stock worth $125,000 after buying an additional 328 shares during the period. 99.55% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at HealthEquity

In other news, Director Robert W. Selander sold 5,750 shares of the stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $111.29, for a total value of $639,917.50. Following the transaction, the director now owns 78,219 shares in the company, valued at $8,704,992.51. This represents a 6.85 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Stuart B. Parker sold 25,000 shares of the stock in a transaction that occurred on Thursday, December 12th. The stock was sold at an average price of $96.72, for a total transaction of $2,418,000.00. Following the completion of the transaction, the director now owns 19,061 shares in the company, valued at $1,843,579.92. This trade represents a 56.74 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 39,000 shares of company stock worth $3,895,788. Company insiders own 2.20% of the company’s stock.

HealthEquity Price Performance

HQY opened at $113.94 on Friday. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. The stock has a market capitalization of $9.87 billion, a P/E ratio of 104.53, a P/E/G ratio of 1.61 and a beta of 0.55. The company’s 50-day simple moving average is $101.90 and its two-hundred day simple moving average is $90.53. HealthEquity, Inc. has a 52-week low of $65.01 and a 52-week high of $115.59.

HealthEquity (NASDAQ:HQY) last posted its earnings results on Monday, December 9th. The company reported $0.59 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same quarter in the prior year, the firm posted $0.40 EPS. As a group, analysts predict that HealthEquity, Inc. will post 2.32 EPS for the current year.

Analyst Ratings Changes

A number of analysts have recently weighed in on the stock. JMP Securities upped their target price on shares of HealthEquity from $105.00 to $107.00 and gave the stock a “market outperform” rating in a research report on Tuesday, December 10th. Bank of America upped their target price on shares of HealthEquity from $100.00 to $120.00 and gave the stock a “buy” rating in a research report on Wednesday, November 13th. The Goldman Sachs Group assumed coverage on shares of HealthEquity in a research report on Friday, November 15th. They issued a “neutral” rating and a $108.00 target price on the stock. Barrington Research increased their price objective on shares of HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a research report on Monday, December 2nd. Finally, BTIG Research increased their price objective on shares of HealthEquity from $110.00 to $130.00 and gave the company a “buy” rating in a research report on Thursday, November 14th. One investment analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $110.71.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.